Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
JACC Basic to Translational Science (2021) - Comments
pubmed: 34904132  doi: 10.1016/j.jacbts.2021.09.013  issn: 2452-302x 

Thorsten M. Leucker, William O. Osburn, Paula Reventun, Kimberley Smith, Brian Claggett, Bridget-Anne Kirwan, Sophie De Brouwer, Marlene S. Williams, Gary Gerstenblith, David N. Hager, Michael B. Streiff, Scott D. Solomon, Charles J. Lowenstein